Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic lupus erythematosus
Authors:
- Vincent BiajouxVBVincent Biajoux
- Alexandre BignonABAlexandre Bignon
- Christelle FreitasCFChristelle Freitas
- Valérie MartinezVMValérie Martinez
- Marcus ThelenMTMarcus Thelen
- Guadalupe LimaGLGuadalupe Lima
- Juan Jakez-OcampoJJJuan Jakez-Ocampo
- Dominique EmilieDEDominique Emilie
- Luis LlorenteLLLuis Llorente
- Karl BalabanianKBKarl Balabanian
Open Access
- 18 December 2012
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 10 (1) , 251
Abstract
Background: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by B-cell hyper-reactivity and the production of pathogenic anti-nuclear-directed auto-antibodies (Abs). B-cell ontogeny is partly dependent on the CXCL12/CXCR4 axis for which the contribution to SLE pathogenesis remains unclear. CXCR7, the novel receptor for CXCL12, is differentially expressed among memory B-cell subsets. However, its biological role in SLE remains to be explored. Methods: Relative CXCR4 and CXCR7 expression levels were compared by quantitative PCR in leukocytes from blood samples of 41 Mexican Mestizos patients with SLE and 45 ethnicity-matched healthy subjects. Intracellular and membrane expression of both receptors was analyzed by flow cytometry in naive and Ab-secreting B cells. B-cell responsiveness to CXCL12 was investigated using Transwell-based chemotaxis assays. Data were analyzed using the Kruskal-Wallis test for comparisons of values amongst healthy controls and patients with inactive or active SLE, and non-parametrically using the Mann–Whitney U-test for multiple comparisons and unpaired samples. Correlations were determined by Spearman’s ranking. Result: SLE leukocytes displayed reduced levels of CXCR4 and CXCR7 transcripts. In SLE patients, a significant defect in CXCR4 expression was detected at the surface of naive and Ab-secreting B cells, associated with an abnormal intracellular localization of the receptor. CXCR7 predominantly localized in cytosolic compartments of B cells from healthy and SLE individuals. Disease activity did not impact on these expression patterns. Altered receptor compartmentalization correlated with an impaired CXCL12-promoted migration of SLE B cells. Conclusions: Our data highlight a down-regulation of CXCL12 receptors on circulating B cells from SLE patients that likely influences their migratory behavior and distribution.Keywords
This publication has 64 references indexed in Scilit:
- Are autoantibodies the targets of B-cell-directed therapy?Nature Reviews Rheumatology, 2011
- Genetic susceptibility to systemic lupus erythematosus in the genomic eraNature Reviews Rheumatology, 2010
- Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosusArthritis Research & Therapy, 2010
- Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patientsArthritis Research & Therapy, 2010
- The role of B cells in lupus pathogenesisThe International Journal of Biochemistry & Cell Biology, 2010
- How chemokines invite leukocytes to danceNature Immunology, 2008
- Systemic Lupus ErythematosusNew England Journal of Medicine, 2008
- Role of anti-DNA antibodies in the pathogenesis of lupus nephritisAutoimmunity Reviews, 2006
- Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosusArthritis & Rheumatism, 2003
- B cells in autoimmunityProceedings of the National Academy of Sciences, 2000